Biome Australia posts record Q2 and H1 FY26 sales
Share
Biome Australia (ASX:BIO) reported record sales for the second quarter and first half of FY26, delivering continued strong growth despite seasonal headwinds.
The company generated Q2 FY26 revenue of $6.5 million, up 40.9% on the previous corresponding period and 9.1% higher than Q1 FY26, a notable result given the quarter is typically softer due to fewer December trading days and pharmacy focus on gifting categories.
Half-year revenue reached $12.4 million, representing a 40.2% increase on H1 FY25, reflecting sustained demand for Biome’s clinically proven Activated Probiotics range.